Top of this page
Skip navigation, go straight to the content
Welcome to UCB IR download center!
You should find all relevant IR-related documents: presentations, annual reports, bond prospectus, code of conduct, etc.
Haven't found what you are looking for? Do not hesitate to contact us: investor-relations@ucb.com
Agreement to acquire
Ra Pharma
On 10 October 2019, UCB announced its intention to acquire Ra Pharma based in Cambridge, MA (U.S.).
This deal is subject to anti-trust clearance & should be completed by the end of Q1 2020.
Upcoming report›
| Date | Event details |
|---|---|
| 20 February 2020 | 2019 full year results 07.00 Press release 14.00 Conference call /webcast Exact timing to be confirmed closer to the time |
UCB IR App
As of 2019, UCB stopped quarterly reporting. We will provide you with an updated IR presentation on a regular basis.
2018 major documents
| 3 months | 6 months | 9 months | 12 months | |
|---|---|---|---|---|
Press release |
|
|
|
|
Presentation |  | | | |
Management report | N.A. |
| N.A. |
|
Excel data | N.A. |  | N.A. | |
2018 full year results
Click replay to listen to the conference call hosted on 28 February 2019.
2018 annual integrated report
2017 annual report
Complementary to the annual report, UCB published a sustainability report. This report is also available in English, French and Dutch.
Corporate governance
Shareholders' meetings
Bonds
Annual reports
2016 annual report
2017 annual report
2017 sustainability report
2013 annual report
2014 annual report
2015 annual report
2010 annual report
2011 annual report
2012 annual report
2009 annual report
2009 CSR report
In 2009, UCB pubslihed for the first time a corporate social responsibility report. The following years, it was part of the annual report.